Dr. Chitra Venkatasubramanian, MD

Dr. Venkatasubramanian practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Venkatasubramanian's NPI, 1912930678, was assigned on July 8, 2006. Dr. Venkatasubramanian graduated from Coimbatore Medical College in 1996. Dr. Venkatasubramanian's California license number on file is A84449.

Dr. Venkatasubramanian's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Venkatasubramanian's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Venkatasubramanian to 1 more hospital and 1 medical group, each named with a free account. Dr. Venkatasubramanian's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Venkatasubramanian practices, 2 sites in all. Vendor and product names are available with a free account.

Vascular neurology is Dr. Venkatasubramanian's primary specialty in the NPI Registry, under taxonomy code 2084V0102X. Dr. Venkatasubramanian is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Venkatasubramanian's licenses on file in 2 states: California and Florida.

Dmand AI lists seizures among the conditions Dr. Venkatasubramanian treats.

CMS data shows 311 Medicare services from Dr. Venkatasubramanian across 4 procedure codes in 2024, for 143 Medicare patients. Medicare paid $53,618 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 143 Medicare patients who saw Dr. Venkatasubramanian in 2024. The largest group is 65 to 74, with 55 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 32% are also on Medicaid. Their average risk score is 2.22, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Venkatasubramanian's median patient age at 58, with 42% women.

In 2024, Dr. Venkatasubramanian wrote 20 Medicare Part D claims. 95% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $28 in total drug cost. In 2018, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Venkatasubramanian for performance year 2024, reported as part of a group. Dr. Venkatasubramanian accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Venkatasubramanian as offering telehealth.

Dmand AI links 22 papers to Dr. Venkatasubramanian, published from 2010 to 2023. 2010 was the busiest year, with 3. The most frequent topics are Cerebral Hemorrhage, Hematoma and Diffusion Magnetic Resonance Imaging. Dr. Venkatasubramanian has published most often in Neurocrit Care. Dr. Venkatasubramanian's most frequent co-authors are Nancy Jane Fischbein, MD, Marion Seaman Buckwalter, MD and Maarten G. Lansberg, MD.

Dmand AI links Dr. Venkatasubramanian to 2 clinical trials, 2 of them phase 3 studies. Conditions studied include Cerebral Hemorrhage and Intracranial Hemorrhages. Johns Hopkins University sponsors the most, 2.

CMS Open Payments shows 187 general payments to Dr. Venkatasubramanian from 12 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 91% of the total. Ceribell, Inc. paid the most, $129,304. It also lists 20 research payments totaling $12,274 from 2018 to 2025.

Dr. Venkatasubramanian graduated from Coimbatore Medical College in 1996.

Dr. Venkatasubramanian is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.